rxstat › Shortages › Pralatrexate

Pralatrexate (Folotyn) shortage status

No current shortage

Source: Health Canada shortage reports · Updated Sep 21, 2026

Pralatrexate has no current shortage reported in Canada. No active reports are on file.
Products affected
0 / 1
Reports on file
1

Reports by product

Resolved
FOLOTYN
20MG · SOLUTION · SERVIER CANADA INC
DIN 02481820 · ended Sep 18, 2026 · Delay in shipping of the drug.

What's happening

There are no active shortage reports for Pralatrexate.

Recent changes

Common questions

When will Pralatrexate be back in stock in Canada?

Pralatrexate has no active shortage; supply is normal per Health Canada reports.

Why is Pralatrexate in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs

Methotrexate (Nordimet) Partial shortage 3 of 31 reported products affected Pemetrexed (Alimta) Partial shortage 4 of 12 reported products affected Capecitabine (Xeloda) Shortage anticipated 0 of 14 reported products affected Cytarabine Shortage anticipated 0 of 3 reported products affected Gemcitabine Shortage anticipated 0 of 9 reported products affected Raltitrexed (Tomudex) Shortage anticipated 0 of 1 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.